{"gene":"FGF5","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1994,"finding":"FGF5 is expressed in the outer root sheath of hair follicles during the anagen VI phase of the hair growth cycle, and loss-of-function mutations (targeted null allele fgf5neo and spontaneous angora go allele) cause abnormally long hair, demonstrating that FGF5 functions as an inhibitor of hair elongation and regulates the anagen-to-catagen transition.","method":"Gene targeting in ES cells (knockout mice), spontaneous mutation complementation test, in situ hybridization for localization","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — loss-of-function by gene targeting + spontaneous allele complementation + localization; foundational paper replicated across multiple species","pmids":["7923352"],"is_preprint":false},{"year":1988,"finding":"FGF5 encodes a secreted growth factor protein with two regions sharing 40–50% homology with acidic and basic FGFs, and the gene has three exons typical of the FGF family; it was identified as a transforming oncogene activated by retrovirus enhancer juxtaposition upstream of the native promoter.","method":"cDNA cloning, sequence analysis, NIH 3T3 transformation assay, Northern blotting in neonatal brain and tumor cell lines","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — original molecular characterization with sequence homology and functional transformation assay; foundational paper with 427 citations","pmids":["3211147"],"is_preprint":false},{"year":2000,"finding":"FGF5 (long form) promotes the anagen-to-catagen transition by inhibiting hair growth, while the alternatively spliced short form FGF5S (lacking exon 2) acts as a partial antagonist of FGF5 by suppressing its catagen-promoting activity when both are co-administered in vivo.","method":"Subcutaneous injection of FGF5 and/or FGF5S protein into depilated mice, histological and morphological analysis of hair follicle phase","journal":"The Journal of investigative dermatology","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo protein administration with defined phenotypic readout; replicated across multiple papers examining the two isoforms","pmids":["10692103"],"is_preprint":false},{"year":1998,"finding":"The alternatively spliced FGF-5S mRNA (lacking exon 2) encodes a 123-amino acid protein that acts as a partial agonist/antagonist of FGF-5 neurotrophic activity in the brain; FGF-5S protein binds FGFR-1 on PC12 cells, partially inhibits FGF-5-induced FGFR-1 tyrosine phosphorylation, but also induces weak phosphorylation by itself, and co-expression with FGF-5 prevents FGF-5-induced differentiation.","method":"cDNA cloning of human and mouse FGF-5S, PC12 cell differentiation assays, FGFR-1 phosphorylation assays, receptor binding competition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — receptor binding, phosphorylation assays and functional differentiation assays with multiple orthogonal methods in a single study","pmids":["9786939"],"is_preprint":false},{"year":1996,"finding":"The rat FGF-5 gene generates a short-form mRNA variant (FGF-5S) by alternative splicing that excludes exon 2, encoding a truncated 121-amino acid protein with an N-terminal sequence identical to the first 117 residues of FGF-5; both mRNAs are expressed in embryo and adult brain.","method":"cDNA cloning and genomic sequencing of rat FGF-5 and variant, Northern blotting","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 — molecular cloning with genomic structure determination; single lab","pmids":["8611621"],"is_preprint":false},{"year":1998,"finding":"FGF5 protein in rat skin is expressed in two compartments: FGF5S is present in hair follicles (detected by antibody reactive with both forms), is hair-cycle dependent (increasing in early anagen VI and decreasing in catagen), while FGF5 long-form is found in macrophage-like cells in the dermis whose density correlates with hair cycle stage.","method":"Immunohistochemistry with isoform-specific monoclonal antibodies on rat skin sections across hair cycle stages","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-specific antibodies with clear localization tied to hair cycle function","pmids":["9856803"],"is_preprint":false},{"year":2001,"finding":"FGF-5 mediates mitogenic signaling through the IIIc splice variant of FGFR-1; TAKA-1 pancreatic ductal cells that secrete FGF-5 but lack FGFR-1 are unresponsive to exogenous FGF-5, but when FGFR-1 IIIc is expressed, FGF-5 stimulates cell growth via the MAPK pathway (blocked by PD98059).","method":"FGFR-1 IIIc cDNA expression in TAKA-1 cells, cell proliferation assays, MAPK activity measurement, pharmacological inhibition","journal":"International journal of pancreatology : official journal of the International Association of Pancreatology","confidence":"Medium","confidence_rationale":"Tier 2 — receptor reconstitution experiment with defined downstream signaling pathway","pmids":["11876253"],"is_preprint":false},{"year":1998,"finding":"FGF5 is vectorially secreted from the basolateral surface of polarized RPE (ARPE-19) cells; over 90% of secreted FGF5 accumulates in the basolateral medium within 6 hours, as demonstrated by domain-selective secretion analysis after adenovirus-mediated gene transfer.","method":"Adenovirus-mediated FGF5 expression in polarized ARPE-19 monolayers, immunoblot analysis of conditioned apical vs. basolateral media","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — direct polarized secretion assay with quantitative immunoblot; single lab","pmids":["9856785"],"is_preprint":false},{"year":2003,"finding":"Endogenous FGF-2 and FGF-5 regulate GFAP expression in astrocytes in a region-specific manner in vivo; FGF-5 deficiency reduces GFAP specifically in the midbrain tegmentum, and FGF-2/FGF-5 double knockout leads to broader GFAP reduction accompanied by reduced intermediate filaments in perivascular astroglial endfeet and enhanced blood-brain barrier permeability.","method":"Single and double mutant mouse analysis, immunohistochemistry, electron microscopy, albumin extravasation assay, tight junction protein (Occludin, ZO-1) Western blotting; FGF-5-/- mice and FGF-2-/-/FGF-5-/- double mutant mice","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double knockout plus multiple orthogonal assays; replicated with rescue experiment","pmids":["12878680"],"is_preprint":false},{"year":2000,"finding":"FGF5 overexpression in developing chick limb mesenchyme stimulates proliferation and expansion of tenascin-expressing connective-tissue fibroblasts (perichondrium) via mitogenic activity, while simultaneously inhibiting skeletal muscle development by reducing MyoD- and myosin heavy chain-expressing cells.","method":"Retroviral (RCAS) misexpression of human FGF5 in chick hind limb, immunohistochemistry for MyoD, myosin heavy chain, tenascin, BrdU pulse-labeling for proliferation","journal":"Developmental dynamics : an official publication of the American Association of Anatomists","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function in vivo with multiple marker readouts; single lab study","pmids":["11066093"],"is_preprint":false},{"year":2005,"finding":"Adenoviral overexpression of FGF-5 in hibernating swine myocardium stimulates cardiac myocyte hypertrophy and reentry into the cell cycle (Ki-67 and phospho-histone H3 positive nuclei increased ~7-fold and ~3.6-fold respectively), improving wall thickening independent of angiogenesis.","method":"Intracoronary injection of replication-deficient adenoviral FGF-5 construct in swine, echocardiography, histological analysis, Ki-67 and phospho-histone H3 immunostaining","journal":"Circulation research","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function in vivo with multiple readouts; direct cellular mechanism identified; single lab","pmids":["15761196"],"is_preprint":false},{"year":2008,"finding":"FGF5 and its predominant receptor FGFR1 IIIc are co-overexpressed in glioblastoma; siRNA-mediated FGF5 knockdown reduces proliferation and migration, while recombinant FGF5 promotes them; FGF5 signals in autocrine and paracrine fashion and stimulates angiogenesis via endothelial cell proliferation, migration, and tube formation.","method":"siRNA knockdown, recombinant FGF5 treatment, dominant-negative FGFR1 IIIc expression, pharmacological FGFR inhibitors, HUVEC assays for proliferation/migration/tube formation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (KD, dominant-negative, pharmacological inhibition, recombinant protein); single lab","pmids":["18362893"],"is_preprint":false},{"year":2014,"finding":"Loss-of-function mutations in FGF5 underlie familial trichomegaly (extreme eyelash growth) in humans; hair follicle organ cultures demonstrate that FGF5 protein induces regression of the human hair follicle, establishing FGF5 as a crucial regulator of human hair length.","method":"Whole exome sequencing and homozygosity mapping of trichomegaly families; hair follicle organ culture with FGF5 treatment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — human genetic identification plus direct functional organ culture experiment; multiple families","pmids":["24989505"],"is_preprint":false},{"year":2020,"finding":"FGF5 signaling via FGFR1 activates downstream androgen/AR and Wnt/β-catenin cascades (including Shh/Gli2, c-MYC, and KRTs) to regulate hair follicle density and wool growth; FGF5 knockout in sheep increases fine-wool and active hair-follicle density through these pathways.","method":"CRISPR/Cas9 FGF5 knockout in Dorper sheep, Western blot, qPCR, IHC, pathway analysis of FGFR1→androgen/AR→Wnt/β-catenin→Shh/Gli2 axis","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — KO model with pathway cascade characterization; single lab","pmids":["32472005"],"is_preprint":false},{"year":2020,"finding":"FGF5 is upregulated in Schwann cells following peripheral nerve injury; exogenous FGF5 inhibits ERK1/2 MAP kinase activity while promoting rapid Schwann cell migration and adhesion through upregulation of N-cadherin, acting as an autocrine regulator.","method":"Microarray and mRNA sequencing, RT-PCR, qPCR, Western blotting, immunostaining of sciatic nerve after injury; FGF5 treatment of cultured primary rat Schwann cells; ERK1/2 phosphorylation assays; N-cadherin expression analysis","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in one study; single lab","pmids":["32848626"],"is_preprint":false},{"year":2003,"finding":"A decapeptide (P3, residues 95–104 of FGF5: VGIGFHLQIY) derived from the receptor-binding region of FGF5 acts as a partial antagonist, suppressing FGF5-induced proliferation of BALB/3T3 and NIH/3T3 fibroblasts and FGFR-1c-transfected Ba/F3 cells, and competes with FGF-5 binding to FGFR-1(IIIc)/Fc chimera; in vivo, P3 reduces FGF-5-mediated inhibition of hair growth and cell proliferation in depilated mice.","method":"In vitro cell proliferation assays, receptor binding competition assay with FGFR-1(IIIc)/Fc chimera, in vivo depilation assay in mice with histological analysis and Ki-67 staining","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 1–2 — in vitro receptor binding plus in vivo functional validation; single lab","pmids":["14502567"],"is_preprint":false},{"year":2019,"finding":"FGF5 promotes osteosarcoma cell proliferation by activating the MAPK signaling pathway; CRISPR/Cas9 knockout of FGF5 reduces MAPK signaling components and inhibits proliferation, while exogenous recombinant FGF5 increases MAPK pathway protein levels and promotes proliferation.","method":"CRISPR/Cas9 FGF5 knockout, recombinant FGF5 treatment, Western blot for MAPK pathway proteins, CCK-8 proliferation assay, xenograft nude mouse model","journal":"Cancer management and research","confidence":"Medium","confidence_rationale":"Tier 2 — KO plus recombinant protein rescue with defined pathway; single lab","pmids":["31372048"],"is_preprint":false},{"year":2022,"finding":"FGF5 overexpression protects cardiomyocytes from LPS-induced pyroptosis by inhibiting the CaMKII/NFκB signaling pathway; FGF5 overexpression reduces p-CaMKII, p-NFκB, NLRP3, caspase-1, IL-1β and IL-18 levels, and the CaMKII inhibitor KN93 mimics this protective effect.","method":"Adenoviral FGF5 overexpression in LPS-treated mice and cardiomyocytes in vitro, echocardiography, Western blot, pharmacological inhibition with KN93","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function in vivo and in vitro with pathway inhibitor validation; single lab","pmids":["36368152"],"is_preprint":false},{"year":2022,"finding":"FGF5 overexpression protects pulmonary vascular endothelial cells from LPS-induced pyroptosis via activation of the AKT signaling pathway; FGF5 overexpression alleviates acute lung injury in mice, and inhibition of AKT with MK2206 abolishes FGF5's protective effect.","method":"Adenoviral FGF5 overexpression in LPS-induced ALI mice, in vitro HUVEC experiments, Western blot, AKT inhibitor (MK2206)","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function in vivo plus pharmacological inhibitor validation of pathway; single lab","pmids":["36244113"],"is_preprint":false},{"year":1998,"finding":"A silencer element in the distal FGF-5 promoter region (-1256/-883) is active specifically in differentiated RPE cells and binds differentiation-specific nuclear protein complexes at two sub-regions (-1195/-1173 and -984/-967), repressing FGF-5 transcription in the differentiated state.","method":"Transfection of FGF-5 promoter/luciferase deletion constructs into proliferating and differentiated RPE cells, gel mobility shift assays with nuclear extracts","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 — promoter deletion analysis plus gel shift assays identifying differentiation-specific complexes; single lab","pmids":["9733582"],"is_preprint":false},{"year":2001,"finding":"FGF-5 mRNA expression in Schwann cells is induced by axotomy (Wallerian degeneration) and suppressed by axon-Schwann cell contact during regeneration; forskolin treatment of cultured Schwann cells also diminishes FGF-5 expression, indicating regulation by the cAMP pathway.","method":"cDNA arrays, Northern blotting, in situ hybridization, Western blotting of axotomized rat sciatic nerve; Schwann cell cultures treated with forskolin","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods linking axon contact to FGF5 expression regulation; single lab","pmids":["11598998"],"is_preprint":false},{"year":2015,"finding":"FGF5s (short form) inhibits the activity of FGF5 in cashmere goat dermal papilla cells; FGF5 overexpression upregulates IGF-1, versican, and noggin while downregulating BMP4, and FGF5s overexpression partially reverses these effects, indicating FGF5s acts as an antagonist of FGF5 at the level of anagen-catagen regulation.","method":"Adenovirus-mediated overexpression of FGF5 and FGF5s in isolated primary and secondary hair follicle dermal papilla cells, qPCR for downstream gene expression","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 — gain-of-function with defined downstream targets and rescue; single lab","pmids":["26390813"],"is_preprint":false},{"year":2021,"finding":"RNA aptamers selected against human FGF5 (e.g., F5f1 with Kd = 0.7 nM, truncated F5f1_56 with Kd = 0.118 nM) specifically inhibit FGF5-induced cell proliferation but not FGF2-induced proliferation, and do not bind FGF1, FGF2, FGF4, FGF6, or FGFR1 with high affinity, demonstrating FGF5-specific receptor activation is required for its mitogenic effect.","method":"SELEX, surface plasmon resonance binding assays, cell proliferation inhibition assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 — SELEX with SPR binding constants and functional proliferation assay; single lab","pmids":["33536494"],"is_preprint":false},{"year":1990,"finding":"The FGF-5 gene is assigned to human chromosome 4 by PCR amplification of somatic cell hybrid DNAs.","method":"PCR-based chromosomal assignment using somatic cell hybrid panel","journal":"BioTechniques","confidence":"Medium","confidence_rationale":"Tier 2 — direct PCR mapping in somatic cell hybrids; chromosomal localization","pmids":["2317376"],"is_preprint":false}],"current_model":"FGF5 is a secreted member of the FGF family that functions as an inhibitor of the anagen phase of the hair growth cycle, being expressed in the outer root sheath during late anagen and signaling through FGFR1 IIIc to promote the anagen-to-catagen transition; an alternatively spliced short isoform (FGF5S/FGF5s) acts as a partial agonist/antagonist by competing at FGFR1, thereby modulating the duration of anagen. Beyond hair biology, FGF5 activates MAPK and AKT signaling to promote cell proliferation and survival in multiple cell types (glioblastoma, osteosarcoma, cardiomyocytes, endothelial cells, Schwann cells), regulates astroglial GFAP expression and blood-brain barrier integrity, stimulates connective-tissue fibroblast proliferation while inhibiting skeletal myogenesis, and is vectorially secreted from the basolateral surface of retinal pigment epithelial cells."},"narrative":{"teleology":[{"year":1988,"claim":"Identification of FGF5 as a secreted FGF family member and transforming oncogene established the gene's molecular identity and its capacity to drive mitogenic signaling.","evidence":"cDNA cloning, sequence homology analysis, and NIH 3T3 transformation assay following retroviral enhancer activation","pmids":["3211147"],"confidence":"High","gaps":["Endogenous physiological function unknown","Receptor specificity not determined","No in vivo loss-of-function data"]},{"year":1994,"claim":"Gene knockout and spontaneous angora mutation demonstrated that FGF5 is a physiological inhibitor of the anagen phase of the hair cycle, resolving its primary in vivo function.","evidence":"Targeted null allele (fgf5neo) and complementation with spontaneous angora (go) mutation in mice; in situ hybridization localizing expression to outer root sheath","pmids":["7923352"],"confidence":"High","gaps":["Receptor mediating the hair cycle effect not identified","Mechanism of catagen induction unknown","No human genetic confirmation yet"]},{"year":1996,"claim":"Discovery of the alternatively spliced short isoform (FGF5S) lacking exon 2 revealed a second gene product with potential distinct function, raising the question of how two isoforms coordinate activity.","evidence":"cDNA cloning and genomic sequencing of rat FGF-5S; Northern blot expression in embryonic and adult brain","pmids":["8611621"],"confidence":"Medium","gaps":["Functional activity of FGF5S not yet tested","Receptor binding properties of FGF5S unknown","Relative expression levels of isoforms in hair follicle undefined"]},{"year":1998,"claim":"Biochemical characterization showed FGF5S acts as a partial agonist/antagonist at FGFR1, competing with full-length FGF5 for receptor binding and partially blocking its signaling — establishing the mechanistic basis for isoform-level regulation.","evidence":"FGFR-1 phosphorylation assays, receptor binding competition, and PC12 differentiation assays","pmids":["9786939"],"confidence":"High","gaps":["Structural basis of partial agonism not resolved","Relative in vivo stoichiometry of isoforms at follicles not quantified"]},{"year":1998,"claim":"Isoform-specific immunolocalization in skin and vectorial basolateral secretion from RPE cells established that FGF5 isoforms occupy distinct tissue compartments and exhibit polarized secretion, informing how directional signaling is achieved.","evidence":"Isoform-specific monoclonal antibodies on rat skin sections across hair cycle; adenovirus-mediated FGF5 expression in polarized ARPE-19 monolayers with domain-selective secretion analysis","pmids":["9856803","9856785"],"confidence":"Medium","gaps":["Basolateral sorting signal in FGF5 not mapped","RPE-specific receptor target not identified","Differentiation-specific silencer element in FGF5 promoter characterized only in vitro"]},{"year":2000,"claim":"In vivo protein administration confirmed that FGF5 promotes catagen while FGF5S antagonizes this effect, and separately, FGF5 was shown to stimulate connective-tissue fibroblast proliferation while inhibiting skeletal myogenesis — broadening FGF5's roles beyond hair.","evidence":"Subcutaneous injection of FGF5/FGF5S in depilated mice; retroviral FGF5 misexpression in chick limb with BrdU, MyoD, and tenascin analysis","pmids":["10692103","11066093"],"confidence":"Medium","gaps":["Downstream transcriptional targets mediating catagen induction not identified","Mechanism of myogenesis inhibition (direct vs. indirect via connective tissue expansion) not resolved"]},{"year":2001,"claim":"Receptor reconstitution experiments identified FGFR1 IIIc as the functional receptor for FGF5 mitogenic signaling via the MAPK pathway, and FGF5 was shown to be regulated by axon-Schwann cell contact after nerve injury.","evidence":"FGFR-1 IIIc cDNA transfection in TAKA-1 cells with MAPK inhibitor PD98059; axotomy model with Northern blot, in situ hybridization, and forskolin treatment of Schwann cells","pmids":["11876253","11598998"],"confidence":"Medium","gaps":["Whether FGFR1 IIIc is the sole receptor in hair follicle not confirmed","Schwann cell functional consequence of FGF5 induction not yet characterized"]},{"year":2003,"claim":"FGF5 was established as a regulator of astroglial GFAP expression and blood-brain barrier integrity through double-knockout mouse studies, revealing a CNS function beyond its known hair cycle role.","evidence":"FGF-5−/− and FGF-2−/−/FGF-5−/− double mutant mice; immunohistochemistry, electron microscopy, albumin extravasation assay","pmids":["12878680"],"confidence":"High","gaps":["Direct vs. indirect effect on tight junction proteins not distinguished","Whether FGF5's BBB role operates through FGFR1 IIIc not tested","Redundancy with other FGFs beyond FGF2 not explored"]},{"year":2008,"claim":"FGF5 was shown to act as an autocrine/paracrine oncogenic factor in glioblastoma, co-overexpressed with FGFR1 IIIc, promoting tumor cell proliferation, migration, and angiogenesis — linking its mitogenic activity to cancer biology.","evidence":"siRNA knockdown, dominant-negative FGFR1 IIIc, pharmacological FGFR inhibitors, HUVEC angiogenesis assays","pmids":["18362893"],"confidence":"Medium","gaps":["Contribution of FGF5 vs. other FGFs to glioblastoma growth in vivo not isolated","Patient outcome correlation not established"]},{"year":2014,"claim":"Human genetic evidence confirmed FGF5 as a causal regulator of hair length in humans, with loss-of-function mutations causing familial trichomegaly and FGF5 protein directly inducing hair follicle regression in organ culture.","evidence":"Whole exome sequencing and homozygosity mapping in trichomegaly families; human hair follicle organ culture treated with FGF5","pmids":["24989505"],"confidence":"High","gaps":["Specific FGFR mediating catagen in human follicles not identified","Genotype-phenotype correlation across different mutations not fully mapped"]},{"year":2019,"claim":"CRISPR knockout confirmed FGF5 promotes osteosarcoma proliferation through the MAPK pathway, extending its role as a mitogenic driver to bone malignancy.","evidence":"CRISPR/Cas9 FGF5 knockout, recombinant FGF5 rescue, Western blot for MAPK components, xenograft model","pmids":["31372048"],"confidence":"Medium","gaps":["Whether FGF5 acts via FGFR1 IIIc in osteosarcoma not directly tested","Therapeutic relevance of FGF5 targeting in bone tumors not assessed"]},{"year":2020,"claim":"Downstream pathway analysis in FGF5-knockout sheep revealed FGF5/FGFR1 activates androgen/AR and Wnt/β-catenin cascades to regulate hair follicle density, and separately, FGF5 was shown to promote Schwann cell migration via N-cadherin upregulation after nerve injury.","evidence":"CRISPR/Cas9 FGF5 KO in Dorper sheep with pathway analysis; FGF5 treatment of primary rat Schwann cells with ERK1/2 phosphorylation and N-cadherin expression analysis","pmids":["32472005","32848626"],"confidence":"Medium","gaps":["Direct binding of FGF5 to AR or β-catenin pathway components not shown","Whether ERK inhibition in Schwann cells is FGFR1-dependent not confirmed","Cross-species conservation of downstream hair follicle cascades not validated"]},{"year":2022,"claim":"FGF5 overexpression was shown to protect cardiomyocytes and pulmonary endothelial cells from pyroptosis through CaMKII/NFκB inhibition and AKT activation respectively, revealing anti-inflammatory cytoprotective roles.","evidence":"Adenoviral FGF5 overexpression in LPS-treated mice and cells; pharmacological inhibitors KN93 (CaMKII) and MK2206 (AKT) for pathway confirmation","pmids":["36368152","36244113"],"confidence":"Medium","gaps":["Whether endogenous FGF5 levels are physiologically relevant for cardioprotection unknown","Receptor mediating these effects not identified","Mechanism linking FGF5 to CaMKII inhibition not elucidated"]},{"year":null,"claim":"The structural basis for FGF5S partial agonism at FGFR1, the identity of the specific FGFR mediating catagen induction in human hair follicles, and whether FGF5's cytoprotective effects in heart and lung reflect a physiological autocrine role remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of FGF5–FGFR1 complex","Physiological relevance of FGF5 in cardiac and pulmonary injury not confirmed with loss-of-function models","Transcriptional program downstream of FGF5 in hair follicle catagen transition not comprehensively defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,2,3,6,11,16]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,2,21]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,7,11]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,11,13,16,17,18]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,9,12]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[11,16]}],"complexes":[],"partners":["FGFR1","FGF2","CDH2"],"other_free_text":[]},"mechanistic_narrative":"FGF5 is a secreted fibroblast growth factor that functions as a key negative regulator of the hair growth cycle by promoting the anagen-to-catagen transition, with loss-of-function mutations causing abnormally long hair in mice and familial trichomegaly in humans [PMID:7923352, PMID:24989505]. FGF5 signals predominantly through the FGFR1 IIIc splice variant to activate MAPK and AKT pathways, driving proliferation and survival in diverse cell types including glioblastoma cells, osteosarcoma cells, cardiomyocytes, and endothelial cells [PMID:11876253, PMID:18362893, PMID:31372048, PMID:36244113]. An alternatively spliced short isoform (FGF5S), lacking exon 2, acts as a partial agonist/antagonist that competes with full-length FGF5 for FGFR1 binding and antagonizes its catagen-promoting and neurotrophic activities [PMID:9786939, PMID:10692103]. Beyond hair and proliferative signaling, FGF5 regulates astroglial GFAP expression and blood–brain barrier integrity, stimulates connective-tissue fibroblast expansion while suppressing myogenesis, and is induced in Schwann cells after peripheral nerve injury where it promotes migration via N-cadherin upregulation [PMID:12878680, PMID:11066093, PMID:32848626]."},"prefetch_data":{"uniprot":{"accession":"P12034","full_name":"Fibroblast growth factor 5","aliases":["Heparin-binding growth factor 5","HBGF-5","Smag-82"],"length_aa":268,"mass_kda":29.6,"function":"Plays an important role in the regulation of cell proliferation and cell differentiation. Required for normal regulation of the hair growth cycle. Functions as an inhibitor of hair elongation by promoting progression from anagen, the growth phase of the hair follicle, into catagen the apoptosis-induced regression phase (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P12034/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FGF5","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FGF5","total_profiled":1310},"omim":[{"mim_id":"610575","title":"R-SPONDIN 2; RSPO2","url":"https://www.omim.org/entry/610575"},{"mim_id":"608245","title":"KERATIN 71, TYPE II; KRT71","url":"https://www.omim.org/entry/608245"},{"mim_id":"604479","title":"SIRTUIN 1; SIRT1","url":"https://www.omim.org/entry/604479"},{"mim_id":"601513","title":"FIBROBLAST GROWTH FACTOR 12; FGF12","url":"https://www.omim.org/entry/601513"},{"mim_id":"190330","title":"TRICHOMEGALY; TCMGLY","url":"https://www.omim.org/entry/190330"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":2.8},{"tissue":"gallbladder","ntpm":2.6},{"tissue":"intestine","ntpm":1.1}],"url":"https://www.proteinatlas.org/search/FGF5"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P12034","domains":[{"cath_id":"2.80.10.50","chopping":"84-218","consensus_level":"high","plddt":96.0739,"start":84,"end":218}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P12034","model_url":"https://alphafold.ebi.ac.uk/files/AF-P12034-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P12034-F1-predicted_aligned_error_v6.png","plddt_mean":75.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FGF5","jax_strain_url":"https://www.jax.org/strain/search?query=FGF5"},"sequence":{"accession":"P12034","fasta_url":"https://rest.uniprot.org/uniprotkb/P12034.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P12034/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P12034"}},"corpus_meta":[{"pmid":"7923352","id":"PMC_7923352","title":"FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/7923352","citation_count":482,"is_preprint":false},{"pmid":"3211147","id":"PMC_3211147","title":"The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors.","date":"1988","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3211147","citation_count":427,"is_preprint":false},{"pmid":"1794311","id":"PMC_1794311","title":"mRNA localization studies suggest that murine FGF-5 plays a role in gastrulation.","date":"1991","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/1794311","citation_count":179,"is_preprint":false},{"pmid":"25998163","id":"PMC_25998163","title":"MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.","date":"2015","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/25998163","citation_count":161,"is_preprint":false},{"pmid":"24989505","id":"PMC_24989505","title":"FGF5 is a crucial regulator of hair length in humans.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24989505","citation_count":135,"is_preprint":false},{"pmid":"26354037","id":"PMC_26354037","title":"Generation of gene-modified goats targeting MSTN and FGF5 via zygote injection of CRISPR/Cas9 system.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26354037","citation_count":133,"is_preprint":false},{"pmid":"12878680","id":"PMC_12878680","title":"Functions of fibroblast growth factor (FGF)-2 and FGF-5 in astroglial differentiation and blood-brain barrier permeability: evidence from mouse mutants.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12878680","citation_count":126,"is_preprint":false},{"pmid":"9856785","id":"PMC_9856785","title":"Use of the ARPE-19 cell line as a model of RPE polarity: basolateral secretion of FGF5.","date":"1998","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/9856785","citation_count":111,"is_preprint":false},{"pmid":"18362893","id":"PMC_18362893","title":"FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.","date":"2008","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/18362893","citation_count":86,"is_preprint":false},{"pmid":"15761196","id":"PMC_15761196","title":"Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle.","date":"2005","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/15761196","citation_count":80,"is_preprint":false},{"pmid":"17433015","id":"PMC_17433015","title":"Mutations within the FGF5 gene are associated with hair length in cats.","date":"2007","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17433015","citation_count":78,"is_preprint":false},{"pmid":"1478282","id":"PMC_1478282","title":"Coexpression of FGF-5 and bFGF by the retinal pigment epithelium in vitro.","date":"1992","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/1478282","citation_count":76,"is_preprint":false},{"pmid":"10692103","id":"PMC_10692103","title":"Dual-mode regulation of hair growth cycle by two Fgf-5 gene products.","date":"2000","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10692103","citation_count":75,"is_preprint":false},{"pmid":"16879338","id":"PMC_16879338","title":"The long and the short of it: evidence that FGF5 is a major determinant of canine 'hair'-itability.","date":"2006","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16879338","citation_count":69,"is_preprint":false},{"pmid":"11319911","id":"PMC_11319911","title":"Two animal models of retinal degeneration are rescued by recombinant adeno-associated virus-mediated production of FGF-5 and FGF-18.","date":"2001","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/11319911","citation_count":67,"is_preprint":false},{"pmid":"20852445","id":"PMC_20852445","title":"Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans.","date":"2011","source":"Journal of hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/20852445","citation_count":67,"is_preprint":false},{"pmid":"27755602","id":"PMC_27755602","title":"Disruption of FGF5 in Cashmere Goats Using CRISPR/Cas9 Results in More Secondary Hair Follicles and Longer Fibers.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27755602","citation_count":65,"is_preprint":false},{"pmid":"9856803","id":"PMC_9856803","title":"Localization of rat FGF-5 protein in skin macrophage-like cells and FGF-5S protein in hair follicle: possible involvement of two Fgf-5 gene products in hair growth cycle regulation.","date":"1998","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/9856803","citation_count":56,"is_preprint":false},{"pmid":"27357248","id":"PMC_27357248","title":"Intrinsic FGF2 and FGF5 promotes angiogenesis of human aortic endothelial cells in 3D microfluidic angiogenesis system.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27357248","citation_count":52,"is_preprint":false},{"pmid":"23384345","id":"PMC_23384345","title":"Allelic heterogeneity of FGF5 mutations causes the long-hair phenotype in dogs.","date":"2013","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23384345","citation_count":50,"is_preprint":false},{"pmid":"28631368","id":"PMC_28631368","title":"CRISPR/Cas9-mediated loss of FGF5 function increases wool staple length in sheep.","date":"2017","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/28631368","citation_count":46,"is_preprint":false},{"pmid":"32472005","id":"PMC_32472005","title":"Crosstalk between androgen and Wnt/β-catenin leads to changes of wool density in FGF5-knockout sheep.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/32472005","citation_count":45,"is_preprint":false},{"pmid":"26390813","id":"PMC_26390813","title":"Fibroblast growth factor 5-short (FGF5s) inhibits the activity of FGF5 in primary and secondary hair follicle dermal papilla cells of cashmere goats.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26390813","citation_count":40,"is_preprint":false},{"pmid":"25927731","id":"PMC_25927731","title":"Two recessive mutations in FGF5 are associated with the long-hair phenotype in donkeys.","date":"2014","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/25927731","citation_count":39,"is_preprint":false},{"pmid":"31272285","id":"PMC_31272285","title":"Downregulation of miR-145-5p elevates retinal ganglion cell survival to delay diabetic retinopathy progress by targeting FGF5.","date":"2019","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31272285","citation_count":34,"is_preprint":false},{"pmid":"8045713","id":"PMC_8045713","title":"Distribution of FGF-5 in the rhesus macaque retina.","date":"1994","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/8045713","citation_count":34,"is_preprint":false},{"pmid":"31372048","id":"PMC_31372048","title":"FGF5 promotes osteosarcoma cells proliferation via activating MAPK signaling pathway.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31372048","citation_count":32,"is_preprint":false},{"pmid":"31276295","id":"PMC_31276295","title":"Base pair editing in goat: nonsense codon introgression into FGF5 results in longer hair.","date":"2019","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31276295","citation_count":32,"is_preprint":false},{"pmid":"29743851","id":"PMC_29743851","title":"MicroRNA-567 inhibits cell proliferation, migration and invasion by targeting FGF5 in osteosarcoma.","date":"2018","source":"EXCLI journal","url":"https://pubmed.ncbi.nlm.nih.gov/29743851","citation_count":31,"is_preprint":false},{"pmid":"11066093","id":"PMC_11066093","title":"FGF5 stimulates expansion of connective tissue fibroblasts and inhibits skeletal muscle development in the limb.","date":"2000","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11066093","citation_count":31,"is_preprint":false},{"pmid":"9786939","id":"PMC_9786939","title":"An alternatively spliced fibroblast growth factor (FGF)-5 mRNA is abundant in brain and translates into a partial agonist/antagonist for FGF-5 neurotrophic activity.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9786939","citation_count":31,"is_preprint":false},{"pmid":"34305588","id":"PMC_34305588","title":"Suppression of FGF5 and FGF18 Expression by Cholesterol-Modified siRNAs Promotes Hair Growth in Mice.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34305588","citation_count":29,"is_preprint":false},{"pmid":"29152117","id":"PMC_29152117","title":"FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29152117","citation_count":28,"is_preprint":false},{"pmid":"33416186","id":"PMC_33416186","title":"Hsa_circ_0016760 exacerbates the malignant development of non‑small cell lung cancer by sponging miR‑145‑5p/FGF5.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/33416186","citation_count":28,"is_preprint":false},{"pmid":"28727005","id":"PMC_28727005","title":"RAPID COMMUNICATION: Generation of FGF5 knockout sheep via the CRISPR/Cas9 system.","date":"2017","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/28727005","citation_count":26,"is_preprint":false},{"pmid":"8611621","id":"PMC_8611621","title":"The rat FGF-5 mRNA variant generated by alternative splicing encodes a novel truncated form of FGF-5.","date":"1996","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/8611621","citation_count":26,"is_preprint":false},{"pmid":"28280377","id":"PMC_28280377","title":"Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process.","date":"2017","source":"Clinical, cosmetic and investigational dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28280377","citation_count":25,"is_preprint":false},{"pmid":"14502567","id":"PMC_14502567","title":"Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5.","date":"2003","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14502567","citation_count":25,"is_preprint":false},{"pmid":"32848626","id":"PMC_32848626","title":"FGF5 Regulates Schwann Cell Migration and Adhesion.","date":"2020","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32848626","citation_count":24,"is_preprint":false},{"pmid":"23394579","id":"PMC_23394579","title":"Characterization of hairless (Hr) and FGF5 genes provides insights into the molecular basis of hair loss in cetaceans.","date":"2013","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/23394579","citation_count":24,"is_preprint":false},{"pmid":"2317376","id":"PMC_2317376","title":"Chromosome assignment by polymerase chain reaction techniques: assignment of the oncogene FGF-5 to human chromosome 4.","date":"1990","source":"BioTechniques","url":"https://pubmed.ncbi.nlm.nih.gov/2317376","citation_count":23,"is_preprint":false},{"pmid":"33536494","id":"PMC_33536494","title":"Specific inhibition of FGF5-induced cell proliferation by RNA aptamers.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33536494","citation_count":20,"is_preprint":false},{"pmid":"9134330","id":"PMC_9134330","title":"Expression of FGF5 in choroidal neovascular membranes associated with ARMD.","date":"1997","source":"Current eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9134330","citation_count":19,"is_preprint":false},{"pmid":"29804124","id":"PMC_29804124","title":"Expression of Fibroblast Growth Factor 5 (FGF5) and Its Influence on Survival of Breast Cancer Patients.","date":"2018","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/29804124","citation_count":18,"is_preprint":false},{"pmid":"34659356","id":"PMC_34659356","title":"Five SNPs Within the FGF5 Gene Significantly Affect Both Wool Traits and Growth Performance in Fine-Wool Sheep (Ovis aries).","date":"2021","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34659356","citation_count":18,"is_preprint":false},{"pmid":"21512271","id":"PMC_21512271","title":"Retrotransposon-mediated Fgf5(go-Utr) mutant mice with long pelage hair.","date":"2011","source":"Experimental animals","url":"https://pubmed.ncbi.nlm.nih.gov/21512271","citation_count":18,"is_preprint":false},{"pmid":"27409080","id":"PMC_27409080","title":"Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27409080","citation_count":17,"is_preprint":false},{"pmid":"11876253","id":"PMC_11876253","title":"Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells.","date":"2001","source":"International journal of pancreatology : official journal of the International Association of Pancreatology","url":"https://pubmed.ncbi.nlm.nih.gov/11876253","citation_count":17,"is_preprint":false},{"pmid":"36368152","id":"PMC_36368152","title":"FGF5 protects heart from sepsis injury by attenuating cardiomyocyte pyroptosis through inhibiting CaMKII/NFκB signaling.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36368152","citation_count":17,"is_preprint":false},{"pmid":"39365728","id":"PMC_39365728","title":"A MSTNDel73C mutation with FGF5 knockout sheep by CRISPR/Cas9 promotes skeletal muscle myofiber hyperplasia.","date":"2024","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/39365728","citation_count":16,"is_preprint":false},{"pmid":"31527639","id":"PMC_31527639","title":"FGF5 methylation is a sensitivity marker of esophageal squamous cell carcinoma to definitive chemoradiotherapy.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31527639","citation_count":16,"is_preprint":false},{"pmid":"26481120","id":"PMC_26481120","title":"A 1-bp deletion in Fgf5 causes male-dominant long hair in the Syrian hamster.","date":"2015","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/26481120","citation_count":16,"is_preprint":false},{"pmid":"9221924","id":"PMC_9221924","title":"Transient expression of FGF-5 mRNA in the rat cerebellar cortex during post-natal development.","date":"1997","source":"Brain research. Molecular brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9221924","citation_count":16,"is_preprint":false},{"pmid":"35380267","id":"PMC_35380267","title":"Genetic susceptibility analysis of FGF5 polymorphism to preeclampsia in Chinese Han population.","date":"2022","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/35380267","citation_count":14,"is_preprint":false},{"pmid":"29024003","id":"PMC_29024003","title":"Molecular characterization of the llama FGF5 gene and identification of putative loss of function mutations.","date":"2017","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29024003","citation_count":14,"is_preprint":false},{"pmid":"33660806","id":"PMC_33660806","title":"SP1-induced lncRNA TUG1 regulates proliferation and apoptosis in islet cells of type 2 diabetes mellitus via the miR-188-3p/FGF5 axis.","date":"2021","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33660806","citation_count":14,"is_preprint":false},{"pmid":"11598998","id":"PMC_11598998","title":"Axon-Schwann cell interactions regulate the expression of fibroblast growth factor-5 (FGF-5).","date":"2001","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/11598998","citation_count":14,"is_preprint":false},{"pmid":"25445274","id":"PMC_25445274","title":"Molecular cloning, characterization, and expression of sheep FGF5 gene.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25445274","citation_count":13,"is_preprint":false},{"pmid":"22634565","id":"PMC_22634565","title":"Cloning and expression analysis of Fgf5, 6 and 7 during early chick development.","date":"2012","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/22634565","citation_count":11,"is_preprint":false},{"pmid":"30757935","id":"PMC_30757935","title":"Eclipta prostrata promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5.","date":"2019","source":"Pharmaceutical biology","url":"https://pubmed.ncbi.nlm.nih.gov/30757935","citation_count":10,"is_preprint":false},{"pmid":"34585489","id":"PMC_34585489","title":"FGF5 and EPAS1 gene polymorphisms are associated with high-altitude adaptation in Nepalese goat breeds.","date":"2021","source":"Animal science journal = Nihon chikusan Gakkaiho","url":"https://pubmed.ncbi.nlm.nih.gov/34585489","citation_count":8,"is_preprint":false},{"pmid":"29307854","id":"PMC_29307854","title":"Evidence of post-transcriptional readthrough regulation in FGF5 gene of alpaca.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/29307854","citation_count":8,"is_preprint":false},{"pmid":"35880306","id":"PMC_35880306","title":"The Lnc-RNA APPAT Suppresses Human Aortic Smooth Muscle Cell Proliferation and Migration by Interacting With MiR-647 and FGF5 in Atherosclerosis.","date":"2022","source":"Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists","url":"https://pubmed.ncbi.nlm.nih.gov/35880306","citation_count":8,"is_preprint":false},{"pmid":"35341378","id":"PMC_35341378","title":"Circ_0041732 regulates tumor properties of triple-negative breast cancer cells by the miR-149-5p/FGF5 pathway.","date":"2022","source":"The International journal of biological markers","url":"https://pubmed.ncbi.nlm.nih.gov/35341378","citation_count":7,"is_preprint":false},{"pmid":"36808266","id":"PMC_36808266","title":"Circ_0001715 Functions as a miR-1249-3p Sponge to Accelerate the Progression of Non-small Cell Lung Cancer via Upregulating the Level of FGF5.","date":"2023","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36808266","citation_count":7,"is_preprint":false},{"pmid":"18779133","id":"PMC_18779133","title":"[Correlation analysis between single nucleotide polymorphism of FGF5 gene and wool yield in rabbits].","date":"2008","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/18779133","citation_count":7,"is_preprint":false},{"pmid":"12754391","id":"PMC_12754391","title":"Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells.","date":"2001","source":"International journal of gastrointestinal cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12754391","citation_count":7,"is_preprint":false},{"pmid":"26535691","id":"PMC_26535691","title":"Alpaca fiber growth is mediated by microRNA let-7b via down-regulation of target gene FGF5.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26535691","citation_count":6,"is_preprint":false},{"pmid":"34432312","id":"PMC_34432312","title":"FGF5 missense mutation is associated with dromedary hair length variation.","date":"2021","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34432312","citation_count":6,"is_preprint":false},{"pmid":"38148937","id":"PMC_38148937","title":"Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.","date":"2023","source":"American journal of clinical and experimental urology","url":"https://pubmed.ncbi.nlm.nih.gov/38148937","citation_count":5,"is_preprint":false},{"pmid":"36244113","id":"PMC_36244113","title":"FGF5 alleviated acute lung injury via AKT signal pathway in endothelial cells.","date":"2022","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/36244113","citation_count":5,"is_preprint":false},{"pmid":"38891117","id":"PMC_38891117","title":"Increasing GSH-Px Activity and Activating Wnt Pathway Promote Fine Wool Growth in FGF5-Edited Sheep.","date":"2024","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/38891117","citation_count":5,"is_preprint":false},{"pmid":"26400346","id":"PMC_26400346","title":"Cloning, molecular characterization, and expression pattern of FGF5 in Cashmere goat (Capra hircus).","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26400346","citation_count":5,"is_preprint":false},{"pmid":"35207492","id":"PMC_35207492","title":"A 90-Day Safety Study of Meat from MSTN and FGF5 Double-Knockout Sheep in Wistar Rats.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35207492","citation_count":5,"is_preprint":false},{"pmid":"37065235","id":"PMC_37065235","title":"Reproduction and viscera organ characteristics of MSTN and FGF5 dual-gene knockout sheep.","date":"2023","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/37065235","citation_count":5,"is_preprint":false},{"pmid":"19273426","id":"PMC_19273426","title":"[Effects of FGF5 gene on fibre traits on Inner Mongolian cashmere goats].","date":"2009","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/19273426","citation_count":5,"is_preprint":false},{"pmid":"9733582","id":"PMC_9733582","title":"Differentiation of retinal pigment epithelial cells in vitro uncovers silencer activity in the FGF-5 gene promoter.","date":"1998","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9733582","citation_count":5,"is_preprint":false},{"pmid":"38926663","id":"PMC_38926663","title":"Metabolic differences in MSTN and FGF5 dual-gene edited sheep muscle cells during myogenesis.","date":"2024","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/38926663","citation_count":4,"is_preprint":false},{"pmid":"40001587","id":"PMC_40001587","title":"Multi-Omics Characterization of Genome-Wide Abnormal DNA Methylation Reveals FGF5 as a Diagnosis of Nasopharyngeal Carcinoma Recurrence After Radiotherapy.","date":"2025","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/40001587","citation_count":4,"is_preprint":false},{"pmid":"37957094","id":"PMC_37957094","title":"FGF5.","date":"2023","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/37957094","citation_count":3,"is_preprint":false},{"pmid":"38674344","id":"PMC_38674344","title":"Regulation of Hair Follicle Growth and Development by Different Alternative Spliceosomes of FGF5 in Rabbits.","date":"2024","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/38674344","citation_count":3,"is_preprint":false},{"pmid":"36905676","id":"PMC_36905676","title":"Fibroblast growth factor 5 (FGF5) and its missense mutant FGF5-H174 underlying trichomegaly: a molecular dynamics simulation investigation.","date":"2023","source":"Journal of biomolecular structure & dynamics","url":"https://pubmed.ncbi.nlm.nih.gov/36905676","citation_count":3,"is_preprint":false},{"pmid":"36916144","id":"PMC_36916144","title":"A rare FGF5 candidate variant (rs112475347) for predisposition to nonsquamous, nonsmall-cell lung cancer.","date":"2023","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36916144","citation_count":3,"is_preprint":false},{"pmid":"35052442","id":"PMC_35052442","title":"Tracing the Origin of the RSPO2 Long-Hair Allele and Epistatic Interaction between FGF5 and RSPO2 in Sapsaree Dog.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/35052442","citation_count":3,"is_preprint":false},{"pmid":"36233155","id":"PMC_36233155","title":"Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36233155","citation_count":3,"is_preprint":false},{"pmid":"11715949","id":"PMC_11715949","title":"Technology evaluation: gene therapy (FGF-5), Vical.","date":"1999","source":"Current opinion in molecular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/11715949","citation_count":3,"is_preprint":false},{"pmid":"35119014","id":"PMC_35119014","title":"The rs1458038 variant near FGF5 is associated with poor response to calcium channel blockers among Filipinos.","date":"2022","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35119014","citation_count":3,"is_preprint":false},{"pmid":"36917699","id":"PMC_36917699","title":"Global Long Noncoding RNA Expression Profiling of MSTN and FGF5 Double-Knockout Sheep Reveals the Key Gatekeepers of Skeletal Muscle Development.","date":"2023","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36917699","citation_count":3,"is_preprint":false},{"pmid":"22567929","id":"PMC_22567929","title":"[Interaction of mutant genes Fgf5(go-Y), we, and wal changes the duration of hair growth cycles in mice].","date":"2012","source":"Ontogenez","url":"https://pubmed.ncbi.nlm.nih.gov/22567929","citation_count":3,"is_preprint":false},{"pmid":"21951799","id":"PMC_21951799","title":"[Cloning, expression analysis and RNA interference of FGF5 gene in sheep].","date":"2011","source":"Yi chuan = Hereditas","url":"https://pubmed.ncbi.nlm.nih.gov/21951799","citation_count":1,"is_preprint":false},{"pmid":"40869975","id":"PMC_40869975","title":"Genetic Variant of the Canine FGF5 Gene for the Hair Length Trait in the Akita: Utility for Hair Coat Variations and Welfare in Conservation Breeding.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40869975","citation_count":0,"is_preprint":false},{"pmid":"41828909","id":"PMC_41828909","title":"Discovery of Four New FGF5 Variants Causing Long Hair in the Dog.","date":"2026","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/41828909","citation_count":0,"is_preprint":false},{"pmid":"41773981","id":"PMC_41773981","title":"FGF5 Allelic Heterogeneity in Long-Haired Belgian Shepherd Dogs.","date":"2026","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41773981","citation_count":0,"is_preprint":false},{"pmid":"40913740","id":"PMC_40913740","title":"FGF5 alleviates ferroptosis in renal tubular epithelial cells by inducing mitophagy under in vitro ischemia-reperfusion-like injury.","date":"2025","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/40913740","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.02.12.637990","title":"A prioritized medium-throughput screen on human stem cell derived insulin secreting beta cells identifies FGF4, FGF5, FGF8F, FGF19 and FGF21 as protective factors","date":"2025-02-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.12.637990","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.29.24318214","title":"Causal relationship between inflammatory cytokines, metabolites and arrhythmia: a mendelian randomization study","date":"2024-12-01","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.29.24318214","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.03.641227","title":"Multiplex-edited mice recapitulate woolly mammoth hair phenotypes","date":"2025-03-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.03.641227","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.19.604327","title":"Long range regulation of transcription scales with genomic distance in a gene specific manner","date":"2024-07-19","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.19.604327","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47927,"output_tokens":6003,"usd":0.116913},"stage2":{"model":"claude-opus-4-6","input_tokens":9607,"output_tokens":3431,"usd":0.200715},"total_usd":0.317628,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"FGF5 is expressed in the outer root sheath of hair follicles during the anagen VI phase of the hair growth cycle, and loss-of-function mutations (targeted null allele fgf5neo and spontaneous angora go allele) cause abnormally long hair, demonstrating that FGF5 functions as an inhibitor of hair elongation and regulates the anagen-to-catagen transition.\",\n      \"method\": \"Gene targeting in ES cells (knockout mice), spontaneous mutation complementation test, in situ hybridization for localization\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — loss-of-function by gene targeting + spontaneous allele complementation + localization; foundational paper replicated across multiple species\",\n      \"pmids\": [\"7923352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"FGF5 encodes a secreted growth factor protein with two regions sharing 40–50% homology with acidic and basic FGFs, and the gene has three exons typical of the FGF family; it was identified as a transforming oncogene activated by retrovirus enhancer juxtaposition upstream of the native promoter.\",\n      \"method\": \"cDNA cloning, sequence analysis, NIH 3T3 transformation assay, Northern blotting in neonatal brain and tumor cell lines\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — original molecular characterization with sequence homology and functional transformation assay; foundational paper with 427 citations\",\n      \"pmids\": [\"3211147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FGF5 (long form) promotes the anagen-to-catagen transition by inhibiting hair growth, while the alternatively spliced short form FGF5S (lacking exon 2) acts as a partial antagonist of FGF5 by suppressing its catagen-promoting activity when both are co-administered in vivo.\",\n      \"method\": \"Subcutaneous injection of FGF5 and/or FGF5S protein into depilated mice, histological and morphological analysis of hair follicle phase\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo protein administration with defined phenotypic readout; replicated across multiple papers examining the two isoforms\",\n      \"pmids\": [\"10692103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The alternatively spliced FGF-5S mRNA (lacking exon 2) encodes a 123-amino acid protein that acts as a partial agonist/antagonist of FGF-5 neurotrophic activity in the brain; FGF-5S protein binds FGFR-1 on PC12 cells, partially inhibits FGF-5-induced FGFR-1 tyrosine phosphorylation, but also induces weak phosphorylation by itself, and co-expression with FGF-5 prevents FGF-5-induced differentiation.\",\n      \"method\": \"cDNA cloning of human and mouse FGF-5S, PC12 cell differentiation assays, FGFR-1 phosphorylation assays, receptor binding competition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — receptor binding, phosphorylation assays and functional differentiation assays with multiple orthogonal methods in a single study\",\n      \"pmids\": [\"9786939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The rat FGF-5 gene generates a short-form mRNA variant (FGF-5S) by alternative splicing that excludes exon 2, encoding a truncated 121-amino acid protein with an N-terminal sequence identical to the first 117 residues of FGF-5; both mRNAs are expressed in embryo and adult brain.\",\n      \"method\": \"cDNA cloning and genomic sequencing of rat FGF-5 and variant, Northern blotting\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular cloning with genomic structure determination; single lab\",\n      \"pmids\": [\"8611621\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF5 protein in rat skin is expressed in two compartments: FGF5S is present in hair follicles (detected by antibody reactive with both forms), is hair-cycle dependent (increasing in early anagen VI and decreasing in catagen), while FGF5 long-form is found in macrophage-like cells in the dermis whose density correlates with hair cycle stage.\",\n      \"method\": \"Immunohistochemistry with isoform-specific monoclonal antibodies on rat skin sections across hair cycle stages\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific antibodies with clear localization tied to hair cycle function\",\n      \"pmids\": [\"9856803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FGF-5 mediates mitogenic signaling through the IIIc splice variant of FGFR-1; TAKA-1 pancreatic ductal cells that secrete FGF-5 but lack FGFR-1 are unresponsive to exogenous FGF-5, but when FGFR-1 IIIc is expressed, FGF-5 stimulates cell growth via the MAPK pathway (blocked by PD98059).\",\n      \"method\": \"FGFR-1 IIIc cDNA expression in TAKA-1 cells, cell proliferation assays, MAPK activity measurement, pharmacological inhibition\",\n      \"journal\": \"International journal of pancreatology : official journal of the International Association of Pancreatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor reconstitution experiment with defined downstream signaling pathway\",\n      \"pmids\": [\"11876253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"FGF5 is vectorially secreted from the basolateral surface of polarized RPE (ARPE-19) cells; over 90% of secreted FGF5 accumulates in the basolateral medium within 6 hours, as demonstrated by domain-selective secretion analysis after adenovirus-mediated gene transfer.\",\n      \"method\": \"Adenovirus-mediated FGF5 expression in polarized ARPE-19 monolayers, immunoblot analysis of conditioned apical vs. basolateral media\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct polarized secretion assay with quantitative immunoblot; single lab\",\n      \"pmids\": [\"9856785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Endogenous FGF-2 and FGF-5 regulate GFAP expression in astrocytes in a region-specific manner in vivo; FGF-5 deficiency reduces GFAP specifically in the midbrain tegmentum, and FGF-2/FGF-5 double knockout leads to broader GFAP reduction accompanied by reduced intermediate filaments in perivascular astroglial endfeet and enhanced blood-brain barrier permeability.\",\n      \"method\": \"Single and double mutant mouse analysis, immunohistochemistry, electron microscopy, albumin extravasation assay, tight junction protein (Occludin, ZO-1) Western blotting; FGF-5-/- mice and FGF-2-/-/FGF-5-/- double mutant mice\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double knockout plus multiple orthogonal assays; replicated with rescue experiment\",\n      \"pmids\": [\"12878680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FGF5 overexpression in developing chick limb mesenchyme stimulates proliferation and expansion of tenascin-expressing connective-tissue fibroblasts (perichondrium) via mitogenic activity, while simultaneously inhibiting skeletal muscle development by reducing MyoD- and myosin heavy chain-expressing cells.\",\n      \"method\": \"Retroviral (RCAS) misexpression of human FGF5 in chick hind limb, immunohistochemistry for MyoD, myosin heavy chain, tenascin, BrdU pulse-labeling for proliferation\",\n      \"journal\": \"Developmental dynamics : an official publication of the American Association of Anatomists\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo with multiple marker readouts; single lab study\",\n      \"pmids\": [\"11066093\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Adenoviral overexpression of FGF-5 in hibernating swine myocardium stimulates cardiac myocyte hypertrophy and reentry into the cell cycle (Ki-67 and phospho-histone H3 positive nuclei increased ~7-fold and ~3.6-fold respectively), improving wall thickening independent of angiogenesis.\",\n      \"method\": \"Intracoronary injection of replication-deficient adenoviral FGF-5 construct in swine, echocardiography, histological analysis, Ki-67 and phospho-histone H3 immunostaining\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo with multiple readouts; direct cellular mechanism identified; single lab\",\n      \"pmids\": [\"15761196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FGF5 and its predominant receptor FGFR1 IIIc are co-overexpressed in glioblastoma; siRNA-mediated FGF5 knockdown reduces proliferation and migration, while recombinant FGF5 promotes them; FGF5 signals in autocrine and paracrine fashion and stimulates angiogenesis via endothelial cell proliferation, migration, and tube formation.\",\n      \"method\": \"siRNA knockdown, recombinant FGF5 treatment, dominant-negative FGFR1 IIIc expression, pharmacological FGFR inhibitors, HUVEC assays for proliferation/migration/tube formation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (KD, dominant-negative, pharmacological inhibition, recombinant protein); single lab\",\n      \"pmids\": [\"18362893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Loss-of-function mutations in FGF5 underlie familial trichomegaly (extreme eyelash growth) in humans; hair follicle organ cultures demonstrate that FGF5 protein induces regression of the human hair follicle, establishing FGF5 as a crucial regulator of human hair length.\",\n      \"method\": \"Whole exome sequencing and homozygosity mapping of trichomegaly families; hair follicle organ culture with FGF5 treatment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — human genetic identification plus direct functional organ culture experiment; multiple families\",\n      \"pmids\": [\"24989505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FGF5 signaling via FGFR1 activates downstream androgen/AR and Wnt/β-catenin cascades (including Shh/Gli2, c-MYC, and KRTs) to regulate hair follicle density and wool growth; FGF5 knockout in sheep increases fine-wool and active hair-follicle density through these pathways.\",\n      \"method\": \"CRISPR/Cas9 FGF5 knockout in Dorper sheep, Western blot, qPCR, IHC, pathway analysis of FGFR1→androgen/AR→Wnt/β-catenin→Shh/Gli2 axis\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO model with pathway cascade characterization; single lab\",\n      \"pmids\": [\"32472005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"FGF5 is upregulated in Schwann cells following peripheral nerve injury; exogenous FGF5 inhibits ERK1/2 MAP kinase activity while promoting rapid Schwann cell migration and adhesion through upregulation of N-cadherin, acting as an autocrine regulator.\",\n      \"method\": \"Microarray and mRNA sequencing, RT-PCR, qPCR, Western blotting, immunostaining of sciatic nerve after injury; FGF5 treatment of cultured primary rat Schwann cells; ERK1/2 phosphorylation assays; N-cadherin expression analysis\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in one study; single lab\",\n      \"pmids\": [\"32848626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A decapeptide (P3, residues 95–104 of FGF5: VGIGFHLQIY) derived from the receptor-binding region of FGF5 acts as a partial antagonist, suppressing FGF5-induced proliferation of BALB/3T3 and NIH/3T3 fibroblasts and FGFR-1c-transfected Ba/F3 cells, and competes with FGF-5 binding to FGFR-1(IIIc)/Fc chimera; in vivo, P3 reduces FGF-5-mediated inhibition of hair growth and cell proliferation in depilated mice.\",\n      \"method\": \"In vitro cell proliferation assays, receptor binding competition assay with FGFR-1(IIIc)/Fc chimera, in vivo depilation assay in mice with histological analysis and Ki-67 staining\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro receptor binding plus in vivo functional validation; single lab\",\n      \"pmids\": [\"14502567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FGF5 promotes osteosarcoma cell proliferation by activating the MAPK signaling pathway; CRISPR/Cas9 knockout of FGF5 reduces MAPK signaling components and inhibits proliferation, while exogenous recombinant FGF5 increases MAPK pathway protein levels and promotes proliferation.\",\n      \"method\": \"CRISPR/Cas9 FGF5 knockout, recombinant FGF5 treatment, Western blot for MAPK pathway proteins, CCK-8 proliferation assay, xenograft nude mouse model\",\n      \"journal\": \"Cancer management and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO plus recombinant protein rescue with defined pathway; single lab\",\n      \"pmids\": [\"31372048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGF5 overexpression protects cardiomyocytes from LPS-induced pyroptosis by inhibiting the CaMKII/NFκB signaling pathway; FGF5 overexpression reduces p-CaMKII, p-NFκB, NLRP3, caspase-1, IL-1β and IL-18 levels, and the CaMKII inhibitor KN93 mimics this protective effect.\",\n      \"method\": \"Adenoviral FGF5 overexpression in LPS-treated mice and cardiomyocytes in vitro, echocardiography, Western blot, pharmacological inhibition with KN93\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo and in vitro with pathway inhibitor validation; single lab\",\n      \"pmids\": [\"36368152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FGF5 overexpression protects pulmonary vascular endothelial cells from LPS-induced pyroptosis via activation of the AKT signaling pathway; FGF5 overexpression alleviates acute lung injury in mice, and inhibition of AKT with MK2206 abolishes FGF5's protective effect.\",\n      \"method\": \"Adenoviral FGF5 overexpression in LPS-induced ALI mice, in vitro HUVEC experiments, Western blot, AKT inhibitor (MK2206)\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function in vivo plus pharmacological inhibitor validation of pathway; single lab\",\n      \"pmids\": [\"36244113\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"A silencer element in the distal FGF-5 promoter region (-1256/-883) is active specifically in differentiated RPE cells and binds differentiation-specific nuclear protein complexes at two sub-regions (-1195/-1173 and -984/-967), repressing FGF-5 transcription in the differentiated state.\",\n      \"method\": \"Transfection of FGF-5 promoter/luciferase deletion constructs into proliferating and differentiated RPE cells, gel mobility shift assays with nuclear extracts\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter deletion analysis plus gel shift assays identifying differentiation-specific complexes; single lab\",\n      \"pmids\": [\"9733582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FGF-5 mRNA expression in Schwann cells is induced by axotomy (Wallerian degeneration) and suppressed by axon-Schwann cell contact during regeneration; forskolin treatment of cultured Schwann cells also diminishes FGF-5 expression, indicating regulation by the cAMP pathway.\",\n      \"method\": \"cDNA arrays, Northern blotting, in situ hybridization, Western blotting of axotomized rat sciatic nerve; Schwann cell cultures treated with forskolin\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking axon contact to FGF5 expression regulation; single lab\",\n      \"pmids\": [\"11598998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FGF5s (short form) inhibits the activity of FGF5 in cashmere goat dermal papilla cells; FGF5 overexpression upregulates IGF-1, versican, and noggin while downregulating BMP4, and FGF5s overexpression partially reverses these effects, indicating FGF5s acts as an antagonist of FGF5 at the level of anagen-catagen regulation.\",\n      \"method\": \"Adenovirus-mediated overexpression of FGF5 and FGF5s in isolated primary and secondary hair follicle dermal papilla cells, qPCR for downstream gene expression\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined downstream targets and rescue; single lab\",\n      \"pmids\": [\"26390813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RNA aptamers selected against human FGF5 (e.g., F5f1 with Kd = 0.7 nM, truncated F5f1_56 with Kd = 0.118 nM) specifically inhibit FGF5-induced cell proliferation but not FGF2-induced proliferation, and do not bind FGF1, FGF2, FGF4, FGF6, or FGFR1 with high affinity, demonstrating FGF5-specific receptor activation is required for its mitogenic effect.\",\n      \"method\": \"SELEX, surface plasmon resonance binding assays, cell proliferation inhibition assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — SELEX with SPR binding constants and functional proliferation assay; single lab\",\n      \"pmids\": [\"33536494\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"The FGF-5 gene is assigned to human chromosome 4 by PCR amplification of somatic cell hybrid DNAs.\",\n      \"method\": \"PCR-based chromosomal assignment using somatic cell hybrid panel\",\n      \"journal\": \"BioTechniques\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct PCR mapping in somatic cell hybrids; chromosomal localization\",\n      \"pmids\": [\"2317376\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FGF5 is a secreted member of the FGF family that functions as an inhibitor of the anagen phase of the hair growth cycle, being expressed in the outer root sheath during late anagen and signaling through FGFR1 IIIc to promote the anagen-to-catagen transition; an alternatively spliced short isoform (FGF5S/FGF5s) acts as a partial agonist/antagonist by competing at FGFR1, thereby modulating the duration of anagen. Beyond hair biology, FGF5 activates MAPK and AKT signaling to promote cell proliferation and survival in multiple cell types (glioblastoma, osteosarcoma, cardiomyocytes, endothelial cells, Schwann cells), regulates astroglial GFAP expression and blood-brain barrier integrity, stimulates connective-tissue fibroblast proliferation while inhibiting skeletal myogenesis, and is vectorially secreted from the basolateral surface of retinal pigment epithelial cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FGF5 is a secreted fibroblast growth factor that functions as a key negative regulator of the hair growth cycle by promoting the anagen-to-catagen transition, with loss-of-function mutations causing abnormally long hair in mice and familial trichomegaly in humans [PMID:7923352, PMID:24989505]. FGF5 signals predominantly through the FGFR1 IIIc splice variant to activate MAPK and AKT pathways, driving proliferation and survival in diverse cell types including glioblastoma cells, osteosarcoma cells, cardiomyocytes, and endothelial cells [PMID:11876253, PMID:18362893, PMID:31372048, PMID:36244113]. An alternatively spliced short isoform (FGF5S), lacking exon 2, acts as a partial agonist/antagonist that competes with full-length FGF5 for FGFR1 binding and antagonizes its catagen-promoting and neurotrophic activities [PMID:9786939, PMID:10692103]. Beyond hair and proliferative signaling, FGF5 regulates astroglial GFAP expression and blood–brain barrier integrity, stimulates connective-tissue fibroblast expansion while suppressing myogenesis, and is induced in Schwann cells after peripheral nerve injury where it promotes migration via N-cadherin upregulation [PMID:12878680, PMID:11066093, PMID:32848626].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Identification of FGF5 as a secreted FGF family member and transforming oncogene established the gene's molecular identity and its capacity to drive mitogenic signaling.\",\n      \"evidence\": \"cDNA cloning, sequence homology analysis, and NIH 3T3 transformation assay following retroviral enhancer activation\",\n      \"pmids\": [\"3211147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous physiological function unknown\", \"Receptor specificity not determined\", \"No in vivo loss-of-function data\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Gene knockout and spontaneous angora mutation demonstrated that FGF5 is a physiological inhibitor of the anagen phase of the hair cycle, resolving its primary in vivo function.\",\n      \"evidence\": \"Targeted null allele (fgf5neo) and complementation with spontaneous angora (go) mutation in mice; in situ hybridization localizing expression to outer root sheath\",\n      \"pmids\": [\"7923352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating the hair cycle effect not identified\", \"Mechanism of catagen induction unknown\", \"No human genetic confirmation yet\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Discovery of the alternatively spliced short isoform (FGF5S) lacking exon 2 revealed a second gene product with potential distinct function, raising the question of how two isoforms coordinate activity.\",\n      \"evidence\": \"cDNA cloning and genomic sequencing of rat FGF-5S; Northern blot expression in embryonic and adult brain\",\n      \"pmids\": [\"8611621\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional activity of FGF5S not yet tested\", \"Receptor binding properties of FGF5S unknown\", \"Relative expression levels of isoforms in hair follicle undefined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Biochemical characterization showed FGF5S acts as a partial agonist/antagonist at FGFR1, competing with full-length FGF5 for receptor binding and partially blocking its signaling — establishing the mechanistic basis for isoform-level regulation.\",\n      \"evidence\": \"FGFR-1 phosphorylation assays, receptor binding competition, and PC12 differentiation assays\",\n      \"pmids\": [\"9786939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of partial agonism not resolved\", \"Relative in vivo stoichiometry of isoforms at follicles not quantified\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Isoform-specific immunolocalization in skin and vectorial basolateral secretion from RPE cells established that FGF5 isoforms occupy distinct tissue compartments and exhibit polarized secretion, informing how directional signaling is achieved.\",\n      \"evidence\": \"Isoform-specific monoclonal antibodies on rat skin sections across hair cycle; adenovirus-mediated FGF5 expression in polarized ARPE-19 monolayers with domain-selective secretion analysis\",\n      \"pmids\": [\"9856803\", \"9856785\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Basolateral sorting signal in FGF5 not mapped\", \"RPE-specific receptor target not identified\", \"Differentiation-specific silencer element in FGF5 promoter characterized only in vitro\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"In vivo protein administration confirmed that FGF5 promotes catagen while FGF5S antagonizes this effect, and separately, FGF5 was shown to stimulate connective-tissue fibroblast proliferation while inhibiting skeletal myogenesis — broadening FGF5's roles beyond hair.\",\n      \"evidence\": \"Subcutaneous injection of FGF5/FGF5S in depilated mice; retroviral FGF5 misexpression in chick limb with BrdU, MyoD, and tenascin analysis\",\n      \"pmids\": [\"10692103\", \"11066093\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream transcriptional targets mediating catagen induction not identified\", \"Mechanism of myogenesis inhibition (direct vs. indirect via connective tissue expansion) not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Receptor reconstitution experiments identified FGFR1 IIIc as the functional receptor for FGF5 mitogenic signaling via the MAPK pathway, and FGF5 was shown to be regulated by axon-Schwann cell contact after nerve injury.\",\n      \"evidence\": \"FGFR-1 IIIc cDNA transfection in TAKA-1 cells with MAPK inhibitor PD98059; axotomy model with Northern blot, in situ hybridization, and forskolin treatment of Schwann cells\",\n      \"pmids\": [\"11876253\", \"11598998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FGFR1 IIIc is the sole receptor in hair follicle not confirmed\", \"Schwann cell functional consequence of FGF5 induction not yet characterized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"FGF5 was established as a regulator of astroglial GFAP expression and blood-brain barrier integrity through double-knockout mouse studies, revealing a CNS function beyond its known hair cycle role.\",\n      \"evidence\": \"FGF-5−/− and FGF-2−/−/FGF-5−/− double mutant mice; immunohistochemistry, electron microscopy, albumin extravasation assay\",\n      \"pmids\": [\"12878680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect effect on tight junction proteins not distinguished\", \"Whether FGF5's BBB role operates through FGFR1 IIIc not tested\", \"Redundancy with other FGFs beyond FGF2 not explored\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"FGF5 was shown to act as an autocrine/paracrine oncogenic factor in glioblastoma, co-overexpressed with FGFR1 IIIc, promoting tumor cell proliferation, migration, and angiogenesis — linking its mitogenic activity to cancer biology.\",\n      \"evidence\": \"siRNA knockdown, dominant-negative FGFR1 IIIc, pharmacological FGFR inhibitors, HUVEC angiogenesis assays\",\n      \"pmids\": [\"18362893\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contribution of FGF5 vs. other FGFs to glioblastoma growth in vivo not isolated\", \"Patient outcome correlation not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Human genetic evidence confirmed FGF5 as a causal regulator of hair length in humans, with loss-of-function mutations causing familial trichomegaly and FGF5 protein directly inducing hair follicle regression in organ culture.\",\n      \"evidence\": \"Whole exome sequencing and homozygosity mapping in trichomegaly families; human hair follicle organ culture treated with FGF5\",\n      \"pmids\": [\"24989505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific FGFR mediating catagen in human follicles not identified\", \"Genotype-phenotype correlation across different mutations not fully mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"CRISPR knockout confirmed FGF5 promotes osteosarcoma proliferation through the MAPK pathway, extending its role as a mitogenic driver to bone malignancy.\",\n      \"evidence\": \"CRISPR/Cas9 FGF5 knockout, recombinant FGF5 rescue, Western blot for MAPK components, xenograft model\",\n      \"pmids\": [\"31372048\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether FGF5 acts via FGFR1 IIIc in osteosarcoma not directly tested\", \"Therapeutic relevance of FGF5 targeting in bone tumors not assessed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Downstream pathway analysis in FGF5-knockout sheep revealed FGF5/FGFR1 activates androgen/AR and Wnt/β-catenin cascades to regulate hair follicle density, and separately, FGF5 was shown to promote Schwann cell migration via N-cadherin upregulation after nerve injury.\",\n      \"evidence\": \"CRISPR/Cas9 FGF5 KO in Dorper sheep with pathway analysis; FGF5 treatment of primary rat Schwann cells with ERK1/2 phosphorylation and N-cadherin expression analysis\",\n      \"pmids\": [\"32472005\", \"32848626\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding of FGF5 to AR or β-catenin pathway components not shown\", \"Whether ERK inhibition in Schwann cells is FGFR1-dependent not confirmed\", \"Cross-species conservation of downstream hair follicle cascades not validated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"FGF5 overexpression was shown to protect cardiomyocytes and pulmonary endothelial cells from pyroptosis through CaMKII/NFκB inhibition and AKT activation respectively, revealing anti-inflammatory cytoprotective roles.\",\n      \"evidence\": \"Adenoviral FGF5 overexpression in LPS-treated mice and cells; pharmacological inhibitors KN93 (CaMKII) and MK2206 (AKT) for pathway confirmation\",\n      \"pmids\": [\"36368152\", \"36244113\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether endogenous FGF5 levels are physiologically relevant for cardioprotection unknown\", \"Receptor mediating these effects not identified\", \"Mechanism linking FGF5 to CaMKII inhibition not elucidated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for FGF5S partial agonism at FGFR1, the identity of the specific FGFR mediating catagen induction in human hair follicles, and whether FGF5's cytoprotective effects in heart and lung reflect a physiological autocrine role remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of FGF5–FGFR1 complex\", \"Physiological relevance of FGF5 in cardiac and pulmonary injury not confirmed with loss-of-function models\", \"Transcriptional program downstream of FGF5 in hair follicle catagen transition not comprehensively defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 2, 3, 6, 11, 16]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 2, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 7, 11]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 11, 13, 16, 17, 18]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 9, 12]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FGFR1\",\n      \"FGF2\",\n      \"CDH2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}